inveox GmbH, founded in 2017, develops systems to digitize, automate and connect pathology laboratories. With an innovative automation system for sample preparation in histopathology, inveox increases efficiency and safety in pathology laboratories. As a result, the risk of operational irregularities and potential misdiagnoses are significantly reduced and patient safety – especially in cancer diagnostics – is greatly improved.
Since its founding, inveox has won numerous awards and was part of several accelerators of renowned companies, such as “Digital Health” (Roche Diagnostics / Plug&Play). In 2017, inveox was voted ‘Start-up of the Year” by Für-Gründer maganzine and made it on the Forbes list of the “100 most promising startups 2018”. At the end of 2018, inveox opened a subsidiary in Poland (Krakow) and in 2019 it became member of the World Economic Forum.